BBI608 and Best Supportive Care vs Placebo and Best Supportive Care in Pretreated Advanced Colorectal Carcinoma

PHASE3CompletedINTERVENTIONAL
Enrollment

282

Participants

Timeline

Start Date

May 10, 2013

Primary Completion Date

May 7, 2016

Study Completion Date

May 16, 2016

Conditions
Colorectal Carcinoma
Interventions
DRUG

BBI608

DRUG

Placebo

OTHER

Best Supportive Care

Trial Locations (63)

2200

Bankstown/ Lidcombe, Bankstown

3002

Peter MacCallum Cancer Institute, East Melbourne

4814

Townsville Hospital, Douglas

5011

The Queen Elizabeth Hospital, Woodville South

5042

Flinders Medical Centre, Bedford Park

5112

Lyell McEwin Hospital, Elizabeth Vale

6008

St John of God - Subiaco, Subiaco

6230

St John of God Bunbury Hospital, Bunbury

7000

Royal Hobart Hospital, Hobart

T2N 4N2

Tom Baker Cancer Centre, Calgary

T6G 1Z2

Cross Cancer Institute, Edmonton

V2S 0C2

BCCA - Abbotsford Centre, Abbotsford

V1Y 5L3

BCCA - Cancer Centre for the Southern Interior, Kelowna

V3V 1Z2

BCCA - Fraser Valley Cancer Centre, Surrey

V5Z 4E6

BCCA - Vancouver Cancer Centre, Vancouver

V8R 6V5

BCCA - Vancouver Island Cancer Centre, Victoria

R3E 0V9

CancerCare Manitoba, Winnipeg

E3B 5N5

Horizon Health Network,, Fredericton

E1C 6Z8

The Moncton Hospital, Moncton

E1C 8X3

The Vitalite Health Network - Dr. Leon Richard, Moncton

E2L 4L2

Atlantic Health Sciences Corporation, Saint John

A1B 3V6

Dr. H. Bliss Murphy Cancer Centre, St. John's

B3H 1V7

QEII Health Sciences Centre, Halifax

L4M 6M2

The Royal Victoria Hospital, Barrie

P3E 5J1

Health Sciences North, Greater Sudbury

L8V 5C2

Juravinski Cancer Centre at Hamilton Health Sciences, Hamilton

N6A 4L6

London Regional Cancer Program, London

L5M 2N1

Credit Valley Hospital, Mississauga

L1G 2B9

Lakeridge Health Oshawa, Oshawa

K1H 8L6

Ottawa Hospital Research Institute, Ottawa

P6B 0A8

Algoma District Cancer Program, Sault Ste. Marie

L2S 0A9

Niagara Health System, St. Catharines

P7B 6V4

Thunder Bay Regional Health Science Centre, Thunder Bay

M4C 3E7

Toronto East General Hospital, Toronto

M4N 3M5

Odette Cancer Centre, Toronto

M5B 1W8

St. Michael's Hospital, Toronto

M5G 1X5

Mount Sinai Hospital, Toronto

M5G 2M9

Univ. Health Network-Princess Margaret Hospital, Toronto

H7M 3L9

Hopital de la Cite-de-la-Sante, Laval

G6V 3Z1

L'Hotel-Dieu de Levis, Lévis

H2L 4M1

CHUM - Hopital Notre-Dame, Montreal

H2W 1S6

McGill University - Dept. Oncology, Montreal

G1R 2J6

CHUQ-Pavillon Hotel-Dieu de Quebec, Québec

G1S 4L8

CHA-Hopital Du St-Sacrement, Québec

J1H 5N4

Centre hospitalier universitaire de Sherbrooke, Sherbrooke

G8Z 3R9

Centre hospitalier regional de Trois-Rivieres, Trois-Rivières

S4T 7T1

Allan Blair Cancer Centre, Regina

S7N 4H4

Saskatoon Cancer Centre, Saskatoon

Unknown

Chiba Cancer Center, Chiba

National Kyushu Cancer Center, Fukuoka

National Cancer Center Hospital East, Kashiwa

Kobe City Medical Center General Hospital, Kobe

National Hospital Organization Shikoku Cancer Center, Matsuyama

Kyorin University Hospital, Mitaka

Aichi Cancer Center Hospital, Nagoya

Osaka Medical Center for Cancer and Cardiovascular Diseases, Osaka

Saitama Prefectural Cancer Center, Saitama

Hokkaido University Hospital, Sapporo

Shizuoka Cancer Center, Shizuoka

Osaka Medical College Hospital, Takatsuki

Cancer Institute Hospital of JFCR, Tokyo

Keio University Hospital, Tokyo

National Cancer Center Hospital, Tokyo

Sponsors
All Listed Sponsors
collaborator

Sumitomo Pharma America, Inc.

INDUSTRY

lead

NCIC Clinical Trials Group

NETWORK